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ABSTRACT 
Objective: 
                  This study was done to study degree of 
relationship between epigastric pain due to gastritis 
caused by use of NSAIDs. 
Design: 
This was observational type of study. 
Duration and time: 
This study was conducted at Mayo Hospital Lahore in 
General Outdoor patient department from july 2017 to 
December 2017. 
Method: 
Every patient taking oral NSAIDs or combination of oral 
NSAIDs and misoprostol twice daily from last two 
months was included in our study. Written consent form 
was signed by each patient to be part of study. A 
questionnaire was made to ask about symptoms of 
patient. The data obtained was analyzed using Microsoft 
excel and spss. 
Results: 
A total of 153 patients were included in our study. 
Patients taking only oral NSAIDs were 97(63.39%) 
whereas those taking combination of Oral NSAIDs and 
Misoprostol were 56 (36.60%).Among the patients who 
were taking oral NSAIDs alone 73(75.25%) developed 
epigastric pain whereas remaining 24( 24.74%) did not 
develop any such symptom. Out of the patients taking 
combination NSAIDs+ misoprostol only 11 (19.64%)  
developed epigastric pain others did not. 
Conclusion: 
 Using NSAIDs can cause gastritis and thus should not 
be prescribed alone. Our study has very well established 
role of Misoprostol in protection of gastric mucosa 
against harmful affects of NSAIDs. 
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INTRODUCTION: 
NSAIDS is the class of drug which inhibits 
Cycloxygenase-1 and Cycloxegenase-2 pathways 
in the synthesis of prostaglandins which are 
involved in the inflammation. Their anti-
inflammatory role is well established and thus these 
drugs are used in the treatment of Painful 
conditions like Rheumatoid arthritis, Osteoarthritis, 
Traumatic injury, Migraine, Tennis elbow, Acute 
gout, low back pain renal colic , menstrual pain and 
in any other painful conditions. NSAIDs are further 
divided into two types. Some are non selective 
which block both COX-1 and COX-2 and others 
are COX-2 selective which has less 
Gastrointestinal side effects[1][2][3][4][5]. 
NSAIDs has many side effects however the most 
common side effects are gastroinstetinal precisely 
gastritis. NSAIDs cause gastro intestinal side 
effects by two ways: direct action of acidic NSAID 
molecules and inhibition of gastroprotective 
prostaglandins by inhbiting COX-1[6]. 
Diminished production of prostaglandins leads to 
increased gastric acid production and decreased 
bicarbonate production. It leads to an overall acidic 
medium in the stomach and damaging the gastric 
mucosa. Apart from gastritis, NSAIDs can cause 
Duodenal and Gastric ulcers as well. Patients of 
gastritis present with Nause, Upper GI abdominal 
pain, diarrhea and dyspepsia. Gastric ulcers present 
with post parandial epigastric pain whereas 
epigastric pain improves after meals in patients of 
gastric ulcers.In severe cases, Upper GI bleeding 
can be a serious consequence of NSAIDs abuse. 
The extent of Gastrointestinal side effects vary. 
Indomethacn and piroxicam have very high side 
effects whereas Ibuprofen and Diclofenac have 
relatively lower risk of side effects 
The treatment of NSAIDs  induced gastritis 
includes stopping use of NSAIDs and use some 
other class for pain relief. Concomitant use of PPIs 
or gastro-protective misoprotsol can diminish side 
effects of NSAIDs abuse. 
MATERIALS AND METHODS: 
This study was an observational type of study 
conducted at Mayo Hospital Lahore from july 2017 
to December 2017. The purpose of this study was 
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to establish the protective benefit of misoprostol 
against Gastrointestinal side effects caused by 
NSAIDs. Our study included only those patients 
who were using NSAIDs or combination of 
NSAIDs and misoprostol twice daily from last two 
month. Any patient not taking NSAIDs regularly 
was not included in our study. Every patient signed 
a written consent form to be the part of study. A 
preformed questionnaire was made to analyse 
symptoms. Data was analysed using Microsoft 
Excel 2010 and SPSS. 
RESULTS: 
A total of 153 patients were included in our study 
with mean age 42.6+2.2 with range from 36-49 
years. 100(65.35%) patients were male whereas 
53(34.64%) patients were female. Patients taking 
only oral NSAIDs were 97(63.39%) whereas those 
taking combination of Oral NSAIDs and 
Misoprostol were 56 (36.60%).Among the patients 
who were taking oral NSAIDs alone 73(75.25%) 
developed epigastric pain whereas remaining 24( 
24.74%) did not develop any such symptom. Out of 
the patients taking combination NSAIDs+ 
misoprostol only 11 (19.64%) developed epigastric 
pain others did not.These results are depicted in 
figure-1 
 Frequency Percentage 
Patients taking NSAIDS 97 63.39% 
Patients taking 
combination of 
NSAIDs+Misoprostol 
56 36.60% 
Total 153 100% 
Table-1: Frequency of patients taking NSAIDs 
versus those taking NSAIDs+Misoprostol 
Combination 
Among the patients who were taking oral NSAIDs 
alone 73(75.25%) developed epigastric pain 
whereas remaining 24( 24.74%) did not develop 
any such symptom. Out of the patients taking 
combination NSAIDs+ misoprostol only 11 
(19.64%)  developed epigastric pain others did not. 
 
Figure1: Comparsion of development of epigastric 
pain in patients taking NSAIDs versus those taking 
NSAIDs+Misoprostcol combination 
A comparative analysis of development of 
Epigastric pain in males versus females was 
asessesd as shown in table-2 
 
 
 
Patients developed Epigastric Pain 
Yes No 
Patients Taking NSAIDs 
Only 
97(63.93%) 
Males 70(72.16%) 60(85.71%) 10(14.28%) 
Females 7(27.83%)         13(48.14%) 14(51.85%) 
Patients Taking 
NSAIDS+Misoprostol 
56(36.60%) 
Males 30(53.57%) 9(30%) 21(70%) 
Females 26(46.42%) 2(7.69%) 24(92.30%) 
 
It was observed that male patients who were taking 
NSAIDs alone, 85.71% of them developed 
epigastric pain in contrast to female patients among 
whom only 48.14% developed epigastric pain. 
Similarly in male patients taking combination of 
Oral NSAIDs+Misoprostol, 30% developed 
epigastric pain whereas in female patients only 
7.69% developed epigastric pain. This shows the 
tendency of developing NSAIDs induced gastritis 
is higher in males.  
DISCUSSION: 
Our results clearly show that prevelance of GI side 
effects is higher in patients taking NSAIDs alone 
without any gastroprotetcive drug. These results are 
also inconsistence with another study conduted by 
J.L Goldstein[7]. 
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In patients using combination of NSAIDs and 
Misoprostol the GI side effects are less likely to 
occur as per our study and it is also similar to study 
conducted by K Shah[8]. 
Another variable studied showed that the male 
patients have more tendency to develop NSAIDs 
induced gastritis than females. Although this was 
an incidental finding. This data is not supported by 
any literature review. 
 
CONCLUSION: 
Misoprostol provides significant protection against 
GI Side effects of NSAIDs. It is thus recommended 
that NSAIDs should not be used alone. There 
should be concomitant use of misoprostol or PPIs 
in patients taking NSAIDs to avoid its adverse 
effects. However, the contraindications of 
misoprostol use must be taken into account which 
include avoiding its use in women of child bearing 
age as it is an abortifacient[9]. 
REFERENCES 
1. Patrick J. Rooney, Walter F. Kean, Yasmin B. Kassam, Murray R. Asch 
Can Med Assoc J. 1985 Mar 15; 132(6): 61 
2. Barrier CH, Hirschowitz BI. Controversies in the detection and management of nonsteroidal 
antiinflammatory drug-induced side effects of the upper gastrointestinal tract. Arthritis Rheum. 1989 
Jul;32(7):926–932. 
3. Armstrong CP, Blower AL. Non-steroidal anti-inflammatory drugs and life threatening complications of 
peptic ulceration. Gut. 1987 May;28(5):527–532 
4. Beardon PH, Brown SV, McDevitt DG. Gastrointestinal events in patients prescribed non-steroidal anti-
inflammatory drugs: a controlled study using record linkage in Tayside. Q J Med. 1989 Jun;71(266):497–
505 
5. M Doherty, R H Hunt, M J Langman, R E Pounder, R I Russell, R D Sturrock, A K Thould Ann Rheum 
Dis. 1987 Aug; 46(8): 640–643 
6. Hawkey CJ, Langman MJ. Non-steroidal anti-inflammatory drugs: overall risks and management. 
Complementary roles for COX-2 inhibitors and proton pump inhibitors. Gut 2003; 52(4): 600-608 
7. Goldstein, J. and Cryer, B. (2015). Gastrointestinal injury associated with NSAID use: a case study and 
review of risk factors and preventative strategies. Drug, Healthcare and Patient Safety, p.31. 
8. Shah, K., Price, K. and Talbot, I. (1995). Effect of longterm misoprostol coadministration with non-steroidal 
anti-inflammatory drugs: a histological study. Gut, 37(2), pp.195-198. 
9. Carbonell JL1, Varela L, Velazco A, Fernández C, Sánchez C (1997). The use of misoprostol for abortion at 
< or = 9 weeks' gestation. Eur J Contracept Reprod Health Care, 2(3), pp.181-5. 
 
